|
1）Gordon RD. Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension. 1986; 8: 93-102
|
|
|
|
2）Wilson FH, Disse-Nicodème S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science. 2001; 293: 1107-12
|
|
|
|
|
|
3）Moriguchi T, Urushiyama S, Hisamoto N, et al. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J Biol Chem. 2005; 280: 42685-93
|
|
|
|
|
|
4）Yang SS, Morimoto T, Rai T, et al. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/.) knockin mouse model. Cell Metab. 2007; 5: 331-44
|
|
|
|
|
|
5）Ohta A, Rai T, Yui N, et al. Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure. Hum Mol Genet. 2009; 18: 3978-86
|
|
|
|
|
|
6）Castaneda-Bueno M, Cervantes-Perez LG, Vazquez N, et al. Activation of the renal Na.:Cl_ cotransporter by angiotensin II is a WNK4-dependent process. Proc Natl Acad Sci U S A. 2012; 109: 7929-34
|
|
|
|
|
|
7）Boyden LM, Choi M, Choate KA, et al. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature. 2012; 482: 98-102
|
|
|
|
|
|
8）Louis-Dit-Picard H, Barc J, Trujillano D, et al. KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet. 2012; 44: 456-60
|
|
|
|
|
|
9）Genschik P, Sumara I, Lechner E. The emerging family of CULLIN3-RING ubiquitin ligases (CRL3 s): cellular functions and disease implications. EMBO J. 2013; 32: 2307-20
|
|
|
|
|
|
10）Adams J, Kelso R, Cooley L. The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol. 2000; 10: 17-24
|
|
|
|
|
|
11）Kigoshi Y, Tsuruta F, Chiba T. Ubiquitin ligase activity of Cul3-KLHL7 protein is attenuated by autosomal dominant retinitis pigmentosa causative mutation. J Biol Chem. 2011; 286: 33613-21
|
|
|
|
|
|
12）Cirak S, von Deimling F, Sachdev S, et al. Kelch-like homologue 9 mutation is associated with an early onset autosomal dominant distal myopathy. Brain. 2010; 133: 2123-35
|
|
|
|
|
|
13）Bomont P, Cavalier L, Blondeau F, et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet. 2000; 26: 370-4
|
|
|
|
|
|
14）Ohta A, Schumacher FR, Mehellou Y, et al. The CUL3-KLHL3 E3 ligase complex mutated in Gordon’s hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction. Biochem J. 2013; 451: 111-22
|
|
|
|
|
|
15）Wakabayashi M, Mori T, Isobe K, et al. Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension. Cell Rep. 2013; 3: 858-68
|
|
|
|
|
|
16）Shibata S, Zhang J, Puthumana J, et al. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4. Proc Natl Acad Sci U S A. 2013; 110: 7838-43
|
|
|
|
|
|
17）Wu G, Peng JB. Disease-causing mutations in KLHL3 impair its effect on WNK4 degradation. FEBS Lett. 2013; 587: 1717-22
|
|
|
|
|
|
18）Mori Y, Wakabayashi M, Mori T, et al. Decrease of WNK4 ubiquitination by disease-causing mutations of KLHL3 through different molecular mechanisms. Biochem Biophys Res Commun. 2013; 439: 30-4
|
|
|
|
|
|
19）Osawa M, Ogura Y, Isobe K, et al. CUL3 gene analysis enables early intervention for pediatric pseudohypoaldosteronism type II in infancy. Pediatr Nephrol. 2013; 28: 1881-4
|
|
|
|
|
|
20）Tsuji S, Yamashita M, Unishi G, et al. A young child with pseudohypoaldosteronism type II by a mutation of Cullin 3. BMC Nephrol. 2013; 14: 166
|
|
|
|
|
|
21）Susa K, Sohara E, Rai T, et al. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice. Hum Mol Genet. 2014; 23: 5052-60
|
|
|
|
|
|
22）Chiga M, Rafiqi FH, Alessi DR, et al. Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade. J Cell Sci. 2011; 124: 1391-5
|
|
|
|
|
|
23）Vallon V, Schroth J, Lang F, et al. Expression and phosphorylation of the Na+-Cl- cotransporter NCC in vivo is regulated by dietary salt, potassium, and SGK1. Am J Physiol Renal Physiol. 2009; 297: F704-12
|
|
|
|
|
|
24）Sohara E, Rai T, Yang SS, et al. Acute insulin stimulation induces phosphorylation of the Na-Cl cotransporter in cultured distal mpkDCT cells and mouse kidney. PLoS One. 2011; 6: e24277
|
|
|
|
|
|
25）Talati G, Ohta A, Rai T, et al. Effect of angiotensin II on the WNK-OSR1/SPAK-NCC phosphorylation cascade in cultured mpkDCT cells and in vivo mouse kidney. Biochem Biophys Res Commun. 2010; 393: 844-8
|
|
|
|
|
|
26）McCormick JA, Ellison DH. The WNKs: atypical protein kinases with pleiotropic actions. Physiol Rev. 2011; 91: 177-219
|
|
|
|
|
|
27）Wilson FH, Kahle KT, Sabath E, et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wildtype but not mutant WNK4. Proc Natl Acad Sci U S A. 2003; 100: 680-4
|
|
|
|
|
|
28）Yang CL, Angell J, Mitchell R, et al. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest. 2003; 111: 1039-45
|
|
|
|
|
|
29）Lalioti MD, Zhang J, Volkman HM, et al. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet. 2006; 38: 1124-32
|
|
|
|
|
|
30）Uchida S. Regulation of blood pressure and renal electrolyte balance by Cullin-RING ligases. Curr Opin Nephrol Hypertens. 2014; 23: 487-93
|
|
|
|
|